Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
about
Immune mechanisms of protection: can adjuvants rise to the challenge?Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporterAssembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia virusesMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadUniversal immunity to influenza must outwit immune evasionInduction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activityPreclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineInduction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinInfluenza and Memory T Cells: How to Awake the ForceA Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsModified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesBroadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentProduction of adenovirus vectors and their use as a delivery system for influenza vaccines.Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infectionEcological and immunological determinants of influenza evolution.Control of influenza virus infection by immunity to conserved viral features.Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic miceBeta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early timeHaemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus.Development of universal influenza vaccines based on influenza virus M and NP genes.Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virusPartial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoproteinCross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virusAntibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.Heterosubtypic immunity to influenza A virus: where do we stand?Toward a broadly protective influenza vaccineInduction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response.Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 MiceGenetic variations of nucleoprotein gene of influenza A viruses isolated from swine in Thailand.Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.Phylodynamics and molecular evolution of influenza A virus nucleoprotein genes in Taiwan between 1979 and 2009.Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in childrenCharacterization of the human CD8⁺ T cell response following infection with 2009 pandemic influenza H1N1 virus.Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccinesCross-protective immune responses elicited by live attenuated influenza vaccinesCross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.
P2860
Q21245319-58B002CB-1D70-4603-AA22-1EB739770DA6Q24336610-81556389-03FD-4C07-A6DF-821CD6A7B960Q24337428-8AF27C8E-25D7-47F7-8583-F6AED2579E80Q24648051-D84A8087-F4F3-42EF-AD19-CFE7271ECF70Q26783897-DA8F9317-05AF-460B-BAED-4BAD4639150BQ26991896-0B650E8C-D8EB-4C45-8607-32D538BADBC5Q27309214-A10FE0E4-20BF-4065-BA1F-D4FCB29CB3FFQ27347652-C6B6736F-85F1-4456-B62D-6C0387673BA6Q27486239-7EC95F01-32F7-45D3-9B2C-EC81823D0C8AQ28070255-2C21181A-6536-4E96-A277-18C7C72FE04EQ30204020-2D6EA2EA-8D1C-43C7-B9D9-9CDCE9146AE7Q30209342-6A576893-AF9B-48EC-9C67-82F3E2418458Q30223058-B89FF55A-E545-4DD4-9EF6-22FECC801D18Q30226873-C91F8250-7807-42E6-B781-C26A3E7E2318Q30226988-2909A0B4-220D-4979-A996-B1D18F8C8309Q30328172-9B76CF72-CE42-433D-B9FA-D28D6F36A626Q30332657-28765720-8B13-42FC-9F3B-F70E6FB64DCFQ30343902-D8FF3EC3-3F85-4AB4-A1E2-2001097B4CB4Q30353698-2E429E00-DB75-4A2F-8D46-6443DF21F1A9Q30353770-2D49EF57-1AC1-4078-BB6D-2B746E30DC80Q30354025-A49AC150-FA3B-47C7-BE3E-3FEE210F29BBQ30355116-7FE10B33-726E-4355-9DBD-D2208E4C9623Q30355817-AD2BF337-02E1-4A2B-9557-2CA7CE8BF8CCQ30363661-4C0AA989-B158-46C9-A19C-5C74129B2371Q30368335-DBB9A747-3F09-4BAF-83FE-7EF1A22A4940Q30368359-532D80F9-6CD1-4256-B9C8-F37BCAFB8C64Q30370995-1283ABA9-0C0B-4A1D-BBA8-12E2645D4956Q30372130-09AA0561-6F8E-4830-8F39-6CAB50BF3698Q30372360-9993CDFE-1DF2-41E1-A1DD-8A97D473FF4DQ30375714-093291D1-EFE8-4193-A470-A6251EE7FFC2Q30379268-4D62B196-9CFD-4698-A96E-FACC00D1B512Q30392456-F8AA05A5-4E63-4628-971E-6A0035F33247Q30392480-67D6DCAF-2CB5-41E6-A018-08FE7AA22116Q30397107-32249352-90AC-46E6-863B-3C25FCFBA819Q30406246-9CE77C49-1594-46E4-8C67-70A465388509Q30406576-76E7F4FB-C74D-4F5F-AAC2-26BD0933709CQ30407075-760BF1C8-EF65-4FD5-B700-005D2B83CC74Q30408295-8E8253A5-2F4B-4381-96FE-9D34022FAFD8Q30426540-3BD4E2AD-0B2A-4E5B-BEB9-42457D5E6DB5Q30426730-0D44B97D-7613-4D6B-B6EC-246F29D438C8
P2860
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influenza A virus nucleoprotei ...... virus cytotoxic T lymphocytes.
@en
Influenza A virus nucleoprotei ...... virus cytotoxic T lymphocytes.
@nl
type
label
Influenza A virus nucleoprotei ...... virus cytotoxic T lymphocytes.
@en
Influenza A virus nucleoprotei ...... virus cytotoxic T lymphocytes.
@nl
prefLabel
Influenza A virus nucleoprotei ...... virus cytotoxic T lymphocytes.
@en
Influenza A virus nucleoprotei ...... virus cytotoxic T lymphocytes.
@nl
P2093
P2860
P356
P1476
Influenza A virus nucleoprotei ...... virus cytotoxic T lymphocytes.
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.6.1785
P407
P577
1985-03-01T00:00:00Z